Supreme Court Asked to Weigh In On the Effect of the Rohrbacher-Farr Amendment

The Rohrbacher-Farr Amendment is a provision that prohibits the federal government (Department of Justice) from prosecuting medical cannabis operations that are in compliance with state law. This Amendment was first passed in 2014 and has been enacted by Congress in every subsequent year. In 2016, the Ninth Circuit Court of Appeals essentially ruled that the Amendment prevented DOJ from spending money on prosecutions against state-compliant medical cannabis operators. Now, according to the petitioner asking for the Supreme Court to weigh in, the First Circuit has interpreted the Amendment differently and is asking for the Supreme Court to resolve the meaning and effect of the Amendment once and for all.

Reading the Petition

If only U.S. would follow Europe’s lead in rescheduling cannabis, medical marijuana could be an excellent and accessible alternative to opioids

Europe’s cannabis market: slow recreational growth but a booming medical industry

While the adult-use market in Europe is taking longer than expected to take shape, the medical cannabis space continues to grow year after year. This is the takeaway that CannIntelligence, an intelligence platform serving the global cannabis industry by providing regulatory and market data, has gathered over years of analyzing the market.”

Continue reading on MMJ Daily